IONM vs. GMVDF, AEMD, TNON, INVO, QNRX, DYNT, NMRD, VERO, STSS, and RSLS
Should you be buying Assure stock or one of its competitors? The main competitors of Assure include G Medical Innovations (GMVDF), Aethlon Medical (AEMD), Tenon Medical (TNON), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Dynatronics (DYNT), Nemaura Medical (NMRD), Venus Concept (VERO), Sharps Technology (STSS), and ReShape Lifesciences (RSLS). These companies are all part of the "surgical & medical instruments" industry.
G Medical Innovations (NASDAQ:GMVDF) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability.
In the previous week, Assure had 3 more articles in the media than G Medical Innovations. MarketBeat recorded 3 mentions for Assure and 0 mentions for G Medical Innovations. Assure's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.
G Medical Innovations has higher revenue and earnings than Assure.
Assure received 3 more outperform votes than G Medical Innovations when rated by MarketBeat users.
6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Assure has a consensus target price of $4.00, suggesting a potential upside of 760.22%. Given G Medical Innovations' higher possible upside, analysts plainly believe Assure is more favorable than G Medical Innovations.
Assure's return on equity of 0.00% beat G Medical Innovations' return on equity.
Summary
G Medical Innovations beats Assure on 6 of the 10 factors compared between the two stocks.
Get Assure News Delivered to You Automatically
Sign up to receive the latest news and ratings for IONM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IONM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
